Amussen Hunsaker Associates LLC BELLICUM PHARMACEUTICALS INC Transaction History

Amussen Hunsaker Associates LLC

  • $715 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 19, 2019
SELL
N/A
-4,373 Closed
0 $0
Q3 2018

Nov 16, 2018
SELL
N/A
-691 Reduced 13.65%
4,373 $19,000
Q2 2018

Aug 16, 2018
BUY
N/A
5,064 New
5,064 $37,000
Track This Portfolio

Track Amussen Hunsaker Associates LLC Portfolio

Follow Amussen Hunsaker Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amussen Hunsaker Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Amussen Hunsaker Associates LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email